Loading…

Allow analytics cookies and session replay? Accepting lets us link visits and completed actions to your account when signed in. Declining keeps cookieless usage counts. The site works either way. Privacy policy

Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 457–462 of 462 KOLs

Sort

Drug: Palonosetron✕

Mohammad Asad, MD

Basic profileOncologyHematology / OncologyMidwest · IL

—
publications: —
h-index: 6
companies

View profile →

James Wade, MD

Basic profileOncologyMedical OncologyMidwest · IL

—
publications: —
h-index: 64
companies

View profile →

Krishna Alluri, MD

Basic profileOncologyHematology / OncologySouth Central · TX

—
publications: —
h-index: 18
companies

View profile →

John Sarantopoulos, MD

UT Health San Antonio

Enriched profileLymphomaMedical OncologySouth Central · TX

—
publications: —
h-index: 10
trials

View profile →

Donald Richards, MD

Texas Oncology-Tyler

Enriched profileGastrointestinalMedical OncologySouth Central · TX

—
publications: —
h-index: 8
trials

View profile →

Ashish Chintakuntlawar, MD

Mayo Clinic Phoenix

Enriched profileBreastMedical OncologyWest · AZ

—
publications: —
h-index: 4
trials

View profile →

← PrevPage 20 of 20Next →

FindMyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Dermatology
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Top experts by indication
KOL finder
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 FindMyKOL